| 1-Pyrrolidinecarboxylic acid, 2-(1H-imidazol-2-yl)-, 1,1-dimethylethyl ester |
2-(1H-咪唑-2-基)吡咯烷-1-羧酸叔丁酯 |
1352719-15-3 |
| 1-Pyrrolidinecarboxylic acid, 2-(5-bromo-1H-imidazol-2-yl)-, 1,1-dimethylethyl ester |
2-(5-溴-1H-咪唑-2-基)吡咯烷-1-羧酸叔丁酯 |
1352718-88-7 |
| XL765 |
XL765 |
1349796-36-6 |
| CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1346168-57-7 |
| PI3K/HDAC Inhibitor |
CUDC-907 |
1339928-25-4 |
| ACY-1215 |
ACY1215 |
1316214-52-4 |
| 6-HYDROXYPYRIDINE-2-BORONIC ACID PINACOL ESTER |
6-羟基吡啶-2-硼酸频哪醇酯 |
1310405-04-9 |
| 4-(1-Methyl-1H-imidazol-2-yl)phenylboronic acid |
(4-(1-甲基-1H-咪唑-2-基)苯基)硼酸 |
1310383-27-7 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| PF-4989216 |
4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈 |
1276553-09-3 |
| AZD1979 |
AZD1979 |
1254035-84-1 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| PRN-1371 |
PRN1371 |
1802929-43-6 |
| 3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide |
3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 |
1232410-49-9 |
| 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole |
6-溴-4-氟-1-异丙基-2-甲基-1H-苯并[D]咪唑 |
1231930-33-8 |
| EPZ020411 |
EPZ020411 盐酸盐的形式 |
1700663-41-7 |
| Tenalisib |
RP6530 |
1639417-53-0 |
| EPZ015666 |
EPZ015666 |
1616391-65-1 |
| GSK-3326595 |
GSK-3326595 |
1616392-22-3 |
| AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
